Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title:Meet Our Editorial Board Member
Volume: 10 Issue: 2
Author(s): Alexander K. C. Leung*
Affiliation:
- Department of Pediatrics, The University of Calgary and Alberta Children's Hospital, Calgary, Alberta,Canada
Export Options
About this article
Cite this article as:
Leung K. C. Alexander*, Meet Our Editorial Board Member, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2016; 10 (2) . https://dx.doi.org/10.2174/187221481002170518175126
DOI https://dx.doi.org/10.2174/187221481002170518175126 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
14
Related Articles
-
Rifaximin: The Revolutionary Antibiotic Approach for Irritable Bowel Syndrome
Mini-Reviews in Medicinal Chemistry PDE-5 Inhibitors: Clinical Points
Current Drug Targets Looking for New Inhibitors for the Epidermal Growth Factor Receptor
Current Topics in Medicinal Chemistry Mast Cells in Allergic and Inflammatory Diseases
Current Pharmaceutical Design The Role of Fibroblast Growth Factor 21 (FGF21) on Energy Balance, Glucose and Lipid Metabolism
Current Diabetes Reviews Dendritic Cells: A New Player in Osteoimmunology
Current Molecular Medicine Cortisol Regulation in Patients with Type 2 Diabetes and the Metabolic Syndrome
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Cardiovascular Effects of Metabolic Surgery on Type 2 Diabetes
Current Cardiology Reviews Clinical Significance of the New Cardiovascular Risk Markers in Diabetes Mellitus
Current Diabetes Reviews Novel Optical Techniques for Imaging Microcirculation in the Diabetic Foot
Current Pharmaceutical Design Foreword
Current Nutrition & Food Science PPAR- γ Agonist in Treatment of Diabetes: Cardiovascular Safety Considerations
Cardiovascular & Hematological Agents in Medicinal Chemistry Patents in Oxidative Stress in Preeclampsia
Recent Patents on Biomarkers 18F-FDG-PET Correlates of Impulse Control Disorder in a Diabetic Patient
Endocrine, Metabolic & Immune Disorders - Drug Targets Reactive Oxygen Species: Physiological Roles in the Regulation of Vascular Cells
Current Molecular Medicine Complications Associated with Recombinant Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke
CNS & Neurological Disorders - Drug Targets Iron Involvement in Multiple Signaling Pathways of Atherosclerosis: A Revisited Hypothesis
Current Medicinal Chemistry FOXO1: A Potential Target for Human Diseases
Current Drug Targets Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability
Current Drug Targets Role of Gut Microbiota in Human Health and Diseases
Current Nutrition & Food Science